BeOne Medicines Ltd. American Depositary Shares ONC
i
Market dataready · fetched 2026-11-13T10:48:54.960Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:00:00.377187379Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T10:48:54.436811+00:00
BeOne Medicines Ltd. American Depositary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 439.81 | 45.4% | 6.4% | 397.59 | 40.0% | 5.1% |
| 25Δ | 435.31 | 44.9% | 5.6% | 401.44 | 39.9% | 4.3% |
| 30Δ | 430.82 | 44.4% | 4.7% | 404.87 | 38.9% | 3.7% |
| 35Δ | 427.14 | 43.9% | 4.1% | 408.30 | 37.9% | 3.1% |
| 40Δ | 423.64 | 43.4% | 3.5% | 411.37 | 37.3% | 2.6% |
| 45Δ | 420.15 | 42.9% | 3.0% | 414.08 | 37.1% | 2.3% |
| 50Δ | 417.01 | 42.9% | 2.6% | 416.79 | 37.0% | 2.0% |
| 55Δ | 413.88 | 42.9% | 2.2% | 419.50 | 36.9% | 1.6% |
| 60Δ | 410.76 | 43.0% | 1.8% | 422.55 | 37.3% | 1.4% |
| 65Δ | 407.26 | 43.4% | 1.6% | 425.69 | 37.9% | 1.1% |
| 70Δ | 403.65 | 44.0% | 1.3% | 428.82 | 38.4% | 0.9% |
| 75Δ | 400.04 | 44.6% | 1.0% | 432.87 | 39.4% | 0.7% |
| 80Δ | 395.14 | 45.5% | 0.8% | 437.47 | 40.5% | 0.5% |
20Δ
- Pseudo strike
- 439.81
- IV
- 45.4%
- B/E move
- 6.4%
- Pseudo strike
- 397.59
- IV
- 40.0%
- B/E move
- 5.1%
25Δ
- Pseudo strike
- 435.31
- IV
- 44.9%
- B/E move
- 5.6%
- Pseudo strike
- 401.44
- IV
- 39.9%
- B/E move
- 4.3%
30Δ
- Pseudo strike
- 430.82
- IV
- 44.4%
- B/E move
- 4.7%
- Pseudo strike
- 404.87
- IV
- 38.9%
- B/E move
- 3.7%
35Δ
- Pseudo strike
- 427.14
- IV
- 43.9%
- B/E move
- 4.1%
- Pseudo strike
- 408.30
- IV
- 37.9%
- B/E move
- 3.1%
40Δ
- Pseudo strike
- 423.64
- IV
- 43.4%
- B/E move
- 3.5%
- Pseudo strike
- 411.37
- IV
- 37.3%
- B/E move
- 2.6%
45Δ
- Pseudo strike
- 420.15
- IV
- 42.9%
- B/E move
- 3.0%
- Pseudo strike
- 414.08
- IV
- 37.1%
- B/E move
- 2.3%
50Δ
- Pseudo strike
- 417.01
- IV
- 42.9%
- B/E move
- 2.6%
- Pseudo strike
- 416.79
- IV
- 37.0%
- B/E move
- 2.0%
55Δ
- Pseudo strike
- 413.88
- IV
- 42.9%
- B/E move
- 2.2%
- Pseudo strike
- 419.50
- IV
- 36.9%
- B/E move
- 1.6%
60Δ
- Pseudo strike
- 410.76
- IV
- 43.0%
- B/E move
- 1.8%
- Pseudo strike
- 422.55
- IV
- 37.3%
- B/E move
- 1.4%
65Δ
- Pseudo strike
- 407.26
- IV
- 43.4%
- B/E move
- 1.6%
- Pseudo strike
- 425.69
- IV
- 37.9%
- B/E move
- 1.1%
70Δ
- Pseudo strike
- 403.65
- IV
- 44.0%
- B/E move
- 1.3%
- Pseudo strike
- 428.82
- IV
- 38.4%
- B/E move
- 0.9%
75Δ
- Pseudo strike
- 400.04
- IV
- 44.6%
- B/E move
- 1.0%
- Pseudo strike
- 432.87
- IV
- 39.4%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 395.14
- IV
- 45.5%
- B/E move
- 0.8%
- Pseudo strike
- 437.47
- IV
- 40.5%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 38.05% | |
| 36.30% | |
| 36.00% | |
| 37.29% | |
| 37.46% | |
| 38.19% | |
| 38.16% | |
| 38.49% | |
| 38.63% | |
| 40.88% |
Biotechnology
ORIC
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. The company is headquartered in South San…
More →ORKA
Oruka Therapeutics, Inc. is a biotechnology company.
More →ORMP
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or…
More →OTLK
Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company…
More →OVID
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is…
More →PBLS
Description unavailable
More →